Fidelity Investments’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$106K Buy
51,320
+549
+1% +$1.14K ﹤0.01% 3582
2025
Q1
$112K Sell
50,771
-141,115
-74% -$310K ﹤0.01% 3508
2024
Q4
$294K Sell
191,886
-240,020
-56% -$367K ﹤0.01% 3111
2024
Q3
$859K Buy
431,906
+89,601
+26% +$178K ﹤0.01% 2642
2024
Q2
$1.2M Buy
342,305
+22,362
+7% +$78.3K ﹤0.01% 2471
2024
Q1
$886K Buy
319,943
+300
+0.1% +$831 ﹤0.01% 2539
2023
Q4
$543K Buy
319,643
+39,144
+14% +$66.5K ﹤0.01% 2663
2023
Q3
$289K Buy
280,499
+4,272
+2% +$4.4K ﹤0.01% 2767
2023
Q2
$320K Buy
276,227
+139,459
+102% +$162K ﹤0.01% 2801
2023
Q1
$207K Buy
136,768
+648
+0.5% +$978 ﹤0.01% 2962
2022
Q4
$340K Sell
136,120
-6,135
-4% -$15.3K ﹤0.01% 2844
2022
Q3
$601K Buy
142,255
+2,087
+1% +$8.82K ﹤0.01% 2739
2022
Q2
$391K Buy
140,168
+5,369
+4% +$15K ﹤0.01% 2920
2022
Q1
$771K Buy
134,799
+7,821
+6% +$44.7K ﹤0.01% 2853
2021
Q4
$1.16M Sell
126,978
-513,632
-80% -$4.69M ﹤0.01% 2658
2021
Q3
$6.85M Buy
640,610
+9,627
+2% +$103K ﹤0.01% 2265
2021
Q2
$9.79M Sell
630,983
-395,868
-39% -$6.14M ﹤0.01% 2118
2021
Q1
$16.6M Sell
1,026,851
-63,965
-6% -$1.04M ﹤0.01% 1857
2020
Q4
$23.1M Sell
1,090,816
-35,072
-3% -$742K ﹤0.01% 1654
2020
Q3
$16.7M Sell
1,125,888
-791,880
-41% -$11.7M ﹤0.01% 1636
2020
Q2
$28.2M Sell
1,917,768
-601,834
-24% -$8.85M ﹤0.01% 1412
2020
Q1
$29.6M Sell
2,519,602
-4,062,808
-62% -$47.7M ﹤0.01% 1246
2019
Q4
$155M Sell
6,582,410
-1,914,379
-23% -$45M 0.02% 747
2019
Q3
$157M Buy
8,496,789
+414,611
+5% +$7.67M 0.02% 706
2019
Q2
$150M Sell
8,082,178
-391,669
-5% -$7.28M 0.02% 752
2019
Q1
$207M Buy
8,473,847
+439,044
+5% +$10.7M 0.02% 631
2018
Q4
$208M Sell
8,034,803
-1,554,710
-16% -$40.3M 0.03% 579
2018
Q3
$304M Sell
9,589,513
-1,701,443
-15% -$53.9M 0.03% 505
2018
Q2
$439M Buy
11,290,956
+693,699
+7% +$27M 0.05% 360
2018
Q1
$292M Buy
10,597,257
+975,248
+10% +$26.9M 0.03% 526
2017
Q4
$174M Buy
9,622,009
+1,506,500
+19% +$27.3M 0.02% 739
2017
Q3
$131M Buy
8,115,509
+66,274
+0.8% +$1.07M 0.02% 856
2017
Q2
$111M Buy
8,049,235
+18,355
+0.2% +$254K 0.01% 931
2017
Q1
$120M Buy
8,030,880
+2,158,041
+37% +$32.4M 0.02% 909
2016
Q4
$76.9M Buy
5,872,839
+20,545
+0.4% +$269K 0.01% 1119
2016
Q3
$101M Buy
5,852,294
+358,874
+7% +$6.18M 0.01% 969
2016
Q2
$99.2M Buy
5,493,420
+63,968
+1% +$1.15M 0.01% 978
2016
Q1
$103M Buy
5,429,452
+39,154
+0.7% +$744K 0.01% 951
2015
Q4
$144M Buy
5,390,298
+40,996
+0.8% +$1.09M 0.02% 807
2015
Q3
$131M Buy
5,349,302
+3,582,141
+203% +$87.4M 0.02% 837
2015
Q2
$55.1M Buy
+1,767,161
New +$55.1M 0.01% 1299
2014
Q3
Sell
-456,320
Closed -$5.62M 2797
2014
Q2
$5.62M Sell
456,320
-31,500
-6% -$388K ﹤0.01% 2210
2014
Q1
$6.79M Buy
+487,820
New +$6.79M ﹤0.01% 2132